2 Firms Vie To Lead Investor Suit Over Co.'s COVID Claims
Robbins Geller Rudman & Dowd LLP and Johnson Fistel LLP seek to jointly lead a proposed class action accusing executives of a biotech company of making empty boasts about the ability...To view the full article, register now.
Already a subscriber? Click here to view full article